-
oa Standardized Criterion of Presepsin Reference Interval for Accurate and Early Diagnosis of Sepsis
- Source: New Emirates Medical Journal, Volume 4, Issue 1, Mar 2023, e030223213419
-
- 29 Apr 2022
- 29 Dec 2022
- 14 Apr 2023
Abstract
Presepsin is a soluble analog of CD14, recently validated as a new biomarker for sepsis. Different cut-off levels of Presepsin for the diagnosis of sepsis have been proposed however, the optimum threshold for early clinical discrimination of sepsis from non-infectious conditions remains unknown.
This work was undertaken to define the reference interval of Presepsin for Sepsis according to the CLSI C28-A3c approved guideline.
Reference individuals (N=72) receiving in-patient care at ICU for sepsis and complications were selected for the study. Presepsin concentrations were measured by enzyme-linked immunosorbent assay. Reference limits were calculated using the non-parametric robust method.
Overall, the reference range for Presepsin in sepsis patients was 24.2 -872.2 pg/mL (90% confidence interval). Peak values for males were relatively higher than for females and the presepsin concentrations were influenced by age.
Proposed reference interval could assist in accurate and early diagnosis of sepsis which would eventually improve the outcome in patients of all age groups.